Aziyo Biologics's market cap is currently ―. The company's EPS TTM is $-2.64; its P/E ratio is -1.24; Aziyo Biologics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 6.69M	$ -4.73M	$ 6.13M	$ 10.30M	$ 13.05M
Gross Profit	$ 2.84M	$ 901.00K	$ 2.84M	$ 980.00K	$ 6.33M
EBIT	$ -18.12M	$ -12.86M	$ -7.06M	$ -9.09M	$ -6.42M
EBITDA	$ -17.20M	$ -11.91M	$ -6.05M	$ -8.08M	$ -5.42M
Net Income Common Stockholders	$ -18.00M	$ -9.31M	$ -9.75M	$ -10.62M	$ -7.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 12.55M	$ 19.28M	$ 14.52M	$ 9.30M	$ 11.79M
Total Assets	$ 35.36M	$ 43.43M	$ 54.58M	$ 52.33M	$ 60.63M
Total Debt	$ 22.01M	$ 23.68M	$ 25.28M	$ 25.64M	$ 25.42M
Net Debt	$ 9.46M	$ 4.40M	$ 10.76M	$ 16.34M	$ 13.63M
Total Liabilities	$ 85.66M	$ 82.03M	$ 84.05M	$ 74.46M	$ 72.81M
Stockholders Equity	$ -50.30M	$ -38.60M	$ -29.47M	$ -22.13M	$ -12.18M
Cash Flow	-
Free Cash Flow	$ -2.62M	$ -9.12M	$ -5.16M	$ -2.47M	$ -5.35M
Operating Cash Flow	$ -2.60M	$ -9.10M	$ -5.10M	$ -2.39M	$ -5.17M
Investing Cash Flow	$ -15.00K	$ 14.54M	$ -62.00K	$ -85.00K	$ -182.00K
Financing Cash Flow	$ -4.07M	$ -695.00K	$ 10.41M	$ -19.00K	$ 148.00K

Currency in USD

Aziyo Biologics Earnings and Revenue History

Income Statement >

Aziyo Biologics Debt to Assets

Balance Sheet >

Aziyo Biologics Cash Flow

Cash Flow >

Aziyo Biologics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing